| 1.57 Data as of 2:02pm ET | -0.05 / -3.09%Today’s Change | 1.07 Today|||52-Week Range 5.19 | +38.01% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $13.1M |
Opexa Therapeutics, Inc. 2635 Technology Forest Boulevard The Woodlands Texas 77381 |

| Neil K. Warma, MBA | President, Chief Executive Officer & Director |
| Donna R. Rill | Senior Vice President-Operations & Quality Systems |
| Karthik Radhakrishnan, CFA, MBA | Chief Financial Officer |
| Kenny S. Frazier | VP-Clinical Development & Regulatory Affairs |
| Donald Healey, PhD | Vice President-Scientific Development |